Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-3β inhibitor 11 (compound 21) is a potent inhibitor of glycogen synthase kinase-3β (GSK-3β) with an inhibitory concentration (IC50) of 10.02 μM. This compound demonstrates potential utility in the field of neurodegenerative disease research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 68.00 | |
10 mg | In stock | $ 109.00 | |
25 mg | In stock | $ 228.00 | |
50 mg | In stock | $ 369.00 | |
100 mg | In stock | $ 591.00 | |
500 mg | In stock | $ 1,260.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | GSK-3β inhibitor 11 (compound 21) is a potent inhibitor of glycogen synthase kinase-3β (GSK-3β) with an inhibitory concentration (IC50) of 10.02 μM. This compound demonstrates potential utility in the field of neurodegenerative disease research [1]. |
Targets&IC50 | GSK-3β:10.02 μM |
Molecular Weight | 393.42 |
Formula | C20H15N3O4S |
CAS No. | 536731-65-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.93 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-3β inhibitor 11 536731-65-4 PI3K/Akt/mTOR signaling Stem Cells GSK-3 inhibitor inhibit